# Hani Enaya

> Hani Enaya is a Series A investor at Sanabil (Riyadh) backing Medical and Software. See 3 investments, check sizes, portfolio. Updated Aug 2026.

- Type: Angel Investor
- Fund: [Sanabil](https://shizune.co/investors/profile/sanabil)
- Location: Riyadh, Saudi Arabia
- Total investments: 3
- Last investment: Aug 2020
- Lead investor: 100%
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/in/henaya/

Hani Enaya is a Series A investor at Sanabil in Riyadh focused on Medical and Software. Hani Enaya is the head of venture capital at Sanabil Investments.

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Medical | 2 | 67% |
| Software | 2 | 67% |
| Health Care | 2 | 67% |
| Apps | 1 | 33% |
| Biotechnology | 1 | 33% |

9 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Series A | 1 | 33% |
| Series B | 1 | 33% |
| Series C | 1 | 33% |

### Country

| Country | Investments | Share |
| --- | --- | --- |
| Saudi Arabia | 1 | 33% |
| United States | 1 | 33% |
| United Arab Emirates | 1 | 33% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Numerion Labs | Atomwise is a preclinical pharma company revolutionizing how drugs are discovered with AI. We invented the use of deep learning for structure-based drug discovery, today developing a pipeline of small-molecule drug candidates advancing into preclinical studies. Our AtomNet® technology has been used to unlock more undruggable targets than any otherAI drug discovery platform. We are tackling over 600 unique disease targets with more than 250 partners around the world, including leading pharmaceutical, agrochemical, and emerging biotechnology companies. Atomwise has raised over $174 million from leading venture capital firms to advance our mission to make better medicines, faster. Learn more at atomwise.com, or connect on Twitter and LinkedIn. | $123M | Series B | Aug 11, 2020 |  |
| Mrsool | MRSOOL connects with people around you who will help you with your tasks! Concierge service affordable to the masses delivered by the crowd. |  | Series A | Mar 12, 2019 |  |
| Vezeeta | Vezeeta is the digital healthcare platform in MEA that connects patients with healthcare providers and health services. Patients are able to search, compare, book, and review the best doctors in Egypt, Saudi Arabia, Jordan, and Lebanon. It also provides innovative SaaS solutions to healthcare providers in the region. Vezeeta empowers millions ofpatients through data and the ability to better access healthcare in the region. With over 200,000 verified reviews, patients are able to search, compare, and book the best doctors in just 1 minute. Doctors also provide Patients with seamless healthcare experiences through our clinic management software. | $12M | Series C | Sep 19, 2018 |  |

3 of 3 investments shown.

## Co-investors
- [Baidu Ventures](https://shizune.co/investors/profile/baidu-ventures) — VC Fund, 1 deal together
- [B Capital](https://shizune.co/investors/profile/b-capital-group) — VC Fund, 1 deal together
- [BECO Capital](https://shizune.co/investors/profile/beco-capital) — VC Fund, 1 deal together
- [Colorcon](https://shizune.co/investors/profile/colorcon) — VC Fund, 1 deal together
- [Crescent Enterprises Venture Capital](https://shizune.co/investors/profile/crescent-enterprises-venture-capital) — VC Fund, 1 deal together
- [DCVC](https://shizune.co/investors/profile/data-collective) — VC Fund, 1 deal together

## About Sanabil

VC Fund · Riyadh, Saudi Arabia

Sanabil Investments is a sovereign wealth fund specializing in direct and fund of funds investments. Its investments are concentrated in direct equity investments, primarily in the Kingdom, and in funds, as well as in diversified investment portfolios. These investments support the growth of the Kingdom’s economy while building internationalinvestment capability and transferring expertise to local Saudi talent.

3 contacts available at Sanabil.

| Name | Title | Profile |
| --- | --- | --- |
| Abdullah Alabduljabbar | CEO | https://shizune.co/investors/profile/abdullah-alabduljabbar-d9c2 |
| Hani Enaya | Head of Venture Capital | https://shizune.co/investors/profile/hani-enaya-09e4 |
| Turki Almalik | Deputy CEO & COO | https://shizune.co/investors/profile/turki-almalik |

## Similar investors

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund

## FAQ

### What does Hani Enaya invest in?

Hani Enaya invests primarily in Medical, Software and Health Care startups, most often at Series A and Series B stage. Most of the 3 investments tracked by Shizune back companies in Saudi Arabia. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### When did Hani Enaya last invest?

The most recent investment recorded for Hani Enaya closed in Aug 2020. Shizune tracks 3 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co